Results
74,087 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Fitzpatrick JenniferCLO and Head of Program Mgmt. |  SIONSionna Therapeutics, Inc.Grant or award | A | — 103.1K sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Fitzpatrick JenniferCLO and Head of Program Mgmt. | SIONSionna Therapeutics, Inc. Grant or award | A | — 103.1K sh |
| Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Option exercise | M | — 400 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Macdonald AndrewSee Remarks |  UBERUber Technologies, IncOption exercise | M | — 1,133 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 2,519 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Derivative conversion | C | $123K 4,035 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,133 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,888 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 687 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 352 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 352 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 687 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | — 900 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Aufderhaar DavidChief Financial Officer |  SFIXStitch Fix, Inc.Option exercise | M | — 43.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $20K 282 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $121K 1,332 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Hanson KristopherGeneral Counsel |  MPLTMapLight Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $193K 16.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 490 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 4,042 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Tax withholding | F | $13K 177 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $31K 439 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 885 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $56K 600 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Kleiser Kirk E.Director |  CLSTCatalyst Bancorp, Inc.Option exercise | M | — 16.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Tax withholding | F | $45K 634 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Alt Aaron EDirector |  KDPKeurig Dr Pepper Inc.Grant or award | A | — 2,752 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 4 | Offer OrChief Executive Officer |  SMWBSIMILARWEB LTD.Open-market sale · 10b5-1 plan | SELL | $384K 45.7K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 4 | Offer OrChief Executive Officer | SMWBSIMILARWEB LTD. Open-market sale · 10b5-1 plan | SELL | $254K 30.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 4 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $225K 7,869 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Derivative conversion · 10b5-1 plan | C | — 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Kumar MukulPRESIDENT, ENGINEERING | PUBMPubMatic, Inc. Option exercise · 10b5-1 plan | M | $17K 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Colis Peter GeorgeDirector, CEO and Secretary |  LIFEEthos Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $12K 315 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 3 | Wang LingkeDirector, President | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $12K 315 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 3 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 15.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Song EstherSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $5,836 63 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 3 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $122K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Kumar MukulPRESIDENT, ENGINEERING | PUBMPubMatic, Inc. Derivative conversion · 10b5-1 plan | C | — 8,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 23.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Azar Samak LChief Legal Officer |  GFSGLOBALFOUNDRIES Inc.Open-market sale · 10b5-1 plan | SELL | $15K 335 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 2 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $62K 15.6K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 2 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $190K 23.4K sh | Sep 18, 2026 traded Sep 16, 2026 |